Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma

NCT02406170 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Neoplasms
Stomach Neoplasms
Neoplasm Metastasis

Interventions

DRUG: Regorafenib
DRUG: Paclitaxel

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)